CHB
Global X China Biotech Innovation ETF
Delisted
CHB was delisted on the 16th of February, 2024.
3 hedge funds and large institutions have $194K invested in Global X China Biotech Innovation ETF in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
–
Holders Change %
0%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Jane Street
New York
|
+$55.3K |
Top Sellers
| 1 |
BBPWM
Blue Bell Private Wealth Management
Blue Bell,
Pennsylvania
|
-$3K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$236 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $180K | +$55.3K | +5,864 | +44% |
|
|
2
UBS Group
Zurich,
Switzerland
| $14.5K | -$236 | -25 | -2% |
|
|
BBPWM
3
Blue Bell Private Wealth Management
Blue Bell,
Pennsylvania
| – | -$3K | -300 | Closed |
|